Literature DB >> 12941471

Beta-secretase (BACE) and GSK-3 mRNA levels in Alzheimer's disease.

Paul Preece1, David J Virley, Moheb Costandi, Robert Coombes, Stephen J Moss, Anne W Mudge, Elena Jazin, Nigel J Cairns.   

Abstract

Beta-secretase (BACE) and glycogen synthase kinase (GSK 3) are two enzymes thought to play a role in Alzheimer's disease. We extracted mRNA from 90 Alzheimer and 81 control brains. Levels of mRNA were quantified for BACE and GSK 3 with TaqMan real-time RT-PCR. We found no change in the Alzheimer's disease brains relative to controls for either the BACE or the GSK 3alpha mRNA levels.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12941471     DOI: 10.1016/s0169-328x(03)00233-x

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  22 in total

1.  Effect of ischemic neuronal insults on amyloid precursor protein processing.

Authors:  Phil Hyu Lee; Eun Mi Hwang; Hyun Seok Hong; Jung Hyun Boo; Inhee Mook-Jung; Kyoon Huh
Journal:  Neurochem Res       Date:  2006-06-21       Impact factor: 3.996

2.  Transcriptional regulation of beta-secretase by p25/cdk5 leads to enhanced amyloidogenic processing.

Authors:  Yi Wen; W Haung Yu; Bryan Maloney; Jason Bailey; Junrong Ma; Isabelle Marié; Thomas Maurin; Lili Wang; Helen Figueroa; Mathieu Herman; Pavan Krishnamurthy; Li Liu; Emmanuel Planel; Lit-Fui Lau; Debomoy K Lahiri; Karen Duff
Journal:  Neuron       Date:  2008-03-13       Impact factor: 17.173

Review 3.  Glycogen synthase kinase-3 signaling in Alzheimer's disease.

Authors:  Elisabetta Lauretti; Ozlem Dincer; Domenico Praticò
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2020-01-30       Impact factor: 4.739

4.  Soluble BACE-1 Activity and sAβPPβ Concentrations in Alzheimer's Disease and Age-Matched Healthy Control Cerebrospinal Fluid from the Alzheimer's Disease Neuroimaging Initiative-1 Baseline Cohort.

Authors:  Mary J Savage; Daniel J Holder; Guoxin Wu; June Kaplow; Judith A Siuciak; William Z Potter
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

5.  MicroRNA-298 and microRNA-328 regulate expression of mouse beta-amyloid precursor protein-converting enzyme 1.

Authors:  Vincent Boissonneault; Isabelle Plante; Serge Rivest; Patrick Provost
Journal:  J Biol Chem       Date:  2008-11-05       Impact factor: 5.157

6.  Sex- and brain region-specific acceleration of β-amyloidogenesis following behavioral stress in a mouse model of Alzheimer's disease.

Authors:  Latha Devi; Melissa J Alldred; Stephen D Ginsberg; Masuo Ohno
Journal:  Mol Brain       Date:  2010-11-08       Impact factor: 4.041

7.  The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1.

Authors:  Wang-Xia Wang; Bernard W Rajeev; Arnold J Stromberg; Na Ren; Guiliang Tang; Qingwei Huang; Isidore Rigoutsos; Peter T Nelson
Journal:  J Neurosci       Date:  2008-01-30       Impact factor: 6.167

8.  Lipid peroxidation up-regulates BACE1 expression in vivo: a possible early event of amyloidogenesis in Alzheimer's disease.

Authors:  Liuji Chen; Ren Na; Mingjun Gu; Arlan Richardson; Qitao Ran
Journal:  J Neurochem       Date:  2008-08-02       Impact factor: 5.372

9.  Metabolic stress modulates Alzheimer's β-secretase gene transcription via SIRT1-PPARγ-PGC-1 in neurons.

Authors:  Ruishan Wang; Jing Jing Li; Shiyong Diao; Young-Don Kwak; Li Liu; Lianteng Zhi; Hansruedi Büeler; Narayan R Bhat; Robert W Williams; Edwards A Park; Francesca-Fang Liao
Journal:  Cell Metab       Date:  2013-05-07       Impact factor: 27.287

10.  MMP13 inhibition rescues cognitive decline in Alzheimer transgenic mice via BACE1 regulation.

Authors:  Bing-Lin Zhu; Yan Long; Wei Luo; Zhen Yan; Yu-Jie Lai; Li-Ge Zhao; Wei-Hui Zhou; Yan-Jiang Wang; Lin-Lin Shen; Lu Liu; Xiao-Juan Deng; Xue-Feng Wang; Fei Sun; Guo-Jun Chen
Journal:  Brain       Date:  2019-01-01       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.